TABLE 01. EXPECTED UPCOMING FDA DECISIONS FOR MIGRAINE DRUGS IN 2018
TABLE 02. GLOBAL MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 03. COMMONLY USED ABORTIVE DRUGS FOR MIGRAINE TREATMENT
TABLE 04. ABORTIVE MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 05. ABORTIVE MIGRAINE DRUGS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 06. PREVENTIVE MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 07. PREVENTIVE MIGRAINE DRUGS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 08. GLOBAL MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 09. ORAL MIGRAINE DRUGS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 10. INJECTABLE MIGRAINE DRUGS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 11. MIGRAINE DRUGS MARKET FOR OTHER ROUTES OF ADMINISTRATION, BY REGION, 2017-2025 ($MILLION)
TABLE 12. GLOBAL MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 13. MIGRAINE DRUGS MARKET FOR RETAIL PHARMACIES, BY REGION, 2017-2025 ($MILLION)
TABLE 14. MIGRAINE DRUGS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2017-2025 ($MILLION)
TABLE 15. MIGRAINE DRUGS MARKET FOR ONLINE PHARMACIES, BY REGION, 2017-2025 ($MILLION)
TABLE 16. MIGRAINE DRUGS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 17. NORTH AMERICA MIGRAINE DRUGS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 18. U.S. MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 19. U.S. MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 20. U.S. MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 21. CANADA MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 22. CANADA MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 23. CANADA MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 24. MEXICO MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 25. MEXICO MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 26. MEXICO MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 27. NORTH AMERICA MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 28. NORTH AMERICA MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 29. NORTH AMERICA MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 30. EUROPE MIGRAINE DRUGS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 31. GERMANY MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 32. GERMANY MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 33. GERMANY MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 34. FRANCE MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 35. FRANCE MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 36. FRANCE MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 37. UK MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 38. UK MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 39. UK MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 40. ITALY MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 41. ITALY MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 42. ITALY MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 43. SPAIN MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 44. SPAIN MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 45. SPAIN MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 46. REST OF EUROPE MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 47. REST OF EUROPE MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 48. REST OF EUROPE MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 49. EUROPE MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 50. EUROPE MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 51. EUROPE MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 52. ASIA-PACIFIC MIGRAINE DRUGS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 53. JAPAN MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 54. JAPAN MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 55. JAPAN MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 56. CHINA MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 57. CHINA MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 58. CHINA MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 59. INDIA MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 60. INDIA MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 61. INDIA MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 62. ITALY MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 63. AUSTRALIA MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 64. AUSTRALIA MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 65. SOUTH KOREA MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 66. SOUTH KOREA MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 67. SOUTH KOREA MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 71. ASIA-PACIFIC MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 72. ASIA-PACIFIC MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 73. ASIA-PACIFIC MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 74. LAMEA MIGRAINE DRUGS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 75. BRAZIL MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 76. BRAZIL MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 77. BRAZIL MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 78. SAUDI ARABIA MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 79. SAUDI ARABIA MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 80. SAUDI ARABIA MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 81. SOUTH AFRICA MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 82. SOUTH AFRICA MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 83. SOUTH AFRICA MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 84. REST OF LAMEA MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 85. REST OF LAMEA MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 86. REST OF LAMEA MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 87. LAMEA MIGRAINE DRUGS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 88. LAMEA MIGRAINE DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2025 ($MILLION)
TABLE 89. LAMEA MIGRAINE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2017-2025 ($MILLION)
TABLE 90. ABBOTT: COMPANY SNAPSHOT
TABLE 91. ABBOTT: OPERATING SEGMENTS
TABLE 92. ABBOTT: PRODUCT PORTFOLIO
TABLE 93. ABBVIE: COMPANY SNAPSHOT
TABLE 94. ABBVIE: OPERATING SEGMENTS
TABLE 95. ABBOTT: PRODUCT PORTFOLIO
TABLE 96. ALLERGAN: COMPANY SNAPSHOT
TABLE 97. ALLERGAN: OPERATING SEGMENTS
TABLE 98. ALLERGAN: PRODUCT PORTFOLIO
TABLE 99. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 100. ASTRAZENECA: OPERATING SEGMENTS
TABLE 101. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 102. EISAI: COMPANY SNAPSHOT
TABLE 103. EISAI: OPERATING SEGMENTS
TABLE 104. EISAI: PRODUCT PORTFOLIO
TABLE 105. ENDO: COMPANY SNAPSHOT
TABLE 106. ENDO: OPERATING SEGMENTS
TABLE 107. ENDO: PRODUCT PORTFOLIO
TABLE 108. GSK: COMPANY SNAPSHOT
TABLE 109. GSK: OPERATING SEGMENTS
TABLE 110. GSK: PRODUCT PORTFOLIO
TABLE 111. J&J: COMPANY SNAPSHOT
TABLE 112. J&J: OPERATING SEGMENTS
TABLE 113. J&J: PRODUCT PORTFOLIO
TABLE 114. MERCK: COMPANY SNAPSHOT
TABLE 115. MERCK: OPERATING SEGMENTS
TABLE 116. MERCK: PRODUCT PORTFOLIO
TABLE 117. PFIZER: COMPANY SNAPSHOT
TABLE 118. PFIZER: OPERATING SEGMENTS
TABLE 119. PFIZER: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 01. MIGRAINE DRUGS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MARKET SHARE ANALYSIS, 2017
FIGURE 04. IMPACT ANALYSES
FIGURE 05. TRIPTANS MARKET, 2017-2025 ($MILLION)
FIGURE 06. ERGOTAMINE DERIVATIVES MARKET, 2017-2025 ($MILLION)
FIGURE 07. OTHER ABORTIVE MIGRAINE DRUGS MARKET, 2017-2025 ($MILLION)
FIGURE 08. COMPARATIVE ANALYSIS OF ABORTIVE MIGRAINE DRUGS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 09. MIGRAINE DRUGS MARKET FOR ANTICONVULSANTS, 2017-2025 ($MILLION)
FIGURE 10. MIGRAINE DRUGS MARKET FOR ANTIDEPRESSANTS, 2017-2025 ($MILLION)
FIGURE 11. MIGRAINE DRUGS MARKET FOR BETA BLOCKERS, 2017-2025 ($MILLION)
FIGURE 12. MIGRAINE DRUGS MARKET FOR OTHER PREVENTIVE MEDICINES, 2017-2025 ($MILLION)
FIGURE 13. COMPARATIVE ANALYSIS OF PREVENTIVE MIGRAINE DRUGS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF ORAL MIGRAINE DRUGS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF INJECTABLE MIGRAINE DRUGS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF MIGRAINE DRUGS MARKET FOR OTHER ROUTES OF ADMINISTRATION, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF MIGRAINE DRUGS MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF MIGRAINE DRUGS MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF MIGRAINE DRUGS MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. FREQUENCY OF ADULTS SUFFERING FROM HEADACHES IN U.S., 2017, BY GENDER
FIGURE 21. ABBOTT: NET SALES, 2015-2017 ($MILLION)
FIGURE 22. ABBOTT: NET SALES SHARE BY OPERATING SEGMENT, 2017 (%)
FIGURE 23. ABBOTT: NET SALES SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 24. ABBVIE: NET SALES, 2015-2017 ($MILLION)
FIGURE 25. ABBVIE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 26. ABBVIE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 27. ALLERGAN: REVENUE, 2015-2017 ($MILLION)
FIGURE 28. ALLERGAN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 29. ASTRAZENECA: REVENUE, 2015-2017 ($MILLION)
FIGURE 30. ASTRAZENECA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 31. EISAI: REVENUE, 2015-2017 ($MILLION)
FIGURE 32. EISAI: REVENUE BY SEGMENT, 2017 (%)
FIGURE 33. REVENUE, 2015-2017 ($MILLION)
FIGURE 34. ENDO: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 35. GSK: REVENUE, 2015-2017 ($MILLION)
FIGURE 36. GSK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37. GSK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 38. J&J: REVENUE, 2015-2017 ($MILLION)
FIGURE 39. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 41. MERCK: NET SALES, 2015-2017 ($MILLION)
FIGURE 42. MERCK: NET SALES BY SEGMENT, 2017 (%)
FIGURE 43. MERCK: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 44. PFIZER: REVENUE, 2015-2017 ($MILLION)
FIGURE 45. PFIZER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 46. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)